BHCM
DDS icon

Brevan Howard Capital Management’s Dillards DDS Stock Holding History

Brevan Howard Capital Management’s Portfolio DDS Stock Details DDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,688
Closed -$1.54M – 2174
2026
Q1 		$1.54M Buy
2,688
+2,057
+326% +$1.28M 0.01% 682
2025
Q4 		$383K Buy
631
+288
+84% +$181K ﹤0.01% 1241
2025
Q3 		$211K Sell
343
-2,316
-87% -$1.2M ﹤0.01% 1726
2025
Q2 		$1.11M Buy
+2,659
New +$992K 0.01% 1013
2025
Q1 		– Sell
-2,343
Closed -$1.01M – 1220
2024
Q4 		$1.01M Buy
+2,343
New +$961K 0.01% 432
2024
Q3 		– Sell
-2,333
Closed -$1.03M – 1197
2024
Q2 		$1.03M Buy
2,333
+742
+47% +$321K 0.01% 365
2024
Q1 		$750K Buy
1,591
+1,042
+190% +$427K 0.01% 345
2023
Q4 		$222K Buy
+549
New +$186K ﹤0.01% 852

Other funds holding DDS

Newport Trust Company
Newport Trust Company Washington, District of Columbia $41.5B AUM 16.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Brevan Howard Capital Management's DDS Position: Q2 2026 in Review

Brevan Howard Capital Management sold out of Dillards (DDS) in Q2 2026, closing a stake of 2,688 shares — an estimated $1.54M sold.

Brevan Howard Capital Management first reported a position in DDS in Q4 2023 and held it in 8 quarters. The position peaked at $1.54M in Q1 2026. 311 funds tracked by Wall St. Rank hold DDS as of Q2 2026.

  • Brevan Howard Capital Management reported no remaining Dillards position as of Q2 2026 after selling out during the quarter.
  • Brevan Howard Capital Management sold 2,688 Dillards shares in Q2 2026, an estimated $1.54M.
  • Brevan Howard Capital Management first reported a position in Dillards in Q4 2023 and held it in 8 quarters.
  • Brevan Howard Capital Management's Dillards position peaked at $1.54M in Q1 2026.
  • 311 funds tracked by Wall St. Rank held Dillards as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.